Signaling Pathways - Cell Experiments - Hepatocellular Carcinoma - Type 2 Diabetes - Colon Cancer
清除全部
- B6032 CB-5083Target: p97Summary: p97抑制剂
- B4763 GKT1378311 CitationTarget: NADPH OxidasesSummary: Nox1/Nox4双重抑制剂
- B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂
- B7641 YC 1中文名: 利非西呱Target: Guanylyl CyclasesSummary: 可溶性鸟苷酸环化酶(sGC)激活剂
- B1410 Amlodipine中文名: 氨氯地平Target: Voltage-gated Calcium Channels (CaV)Summary: 钙通道阻滞剂
- B2198 Nateglinide中文名: 那格列奈Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 胰岛素促分泌剂
- B2195 Gliclazide中文名: 格列齐特Target: Inward Rectifier Potassium (Kir) ChannelsSummary: 钾通道抑制剂
- B2194 Tolbutamide中文名: 甲苯磺丁脲Target: cAMP|Sulfonylurea receptorsSummary: 第一代钾通道阻滞剂
- B2283 Niclosamide中文名: 氯硝柳胺Target: STATSummary: STAT3信号通路抑制剂
- B1858 Tranexamic Acid中文名: 氨甲环酸Target: fibrinolysisSummary: 纤溶酶原激活的竞争性抑制剂